MiMedx Group Inc.

NASDAQ: MDXG · Real-Time Price · USD
7.10
-0.05 (-0.70%)
At close: Aug 15, 2025, 3:59 PM
7.11
0.13%
After-hours: Aug 15, 2025, 04:20 PM EDT

MiMedx Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
348.88M 321.48M 267.84M 258.62M
Cost of Revenue
60.07M 54.63M 48.32M 43.28M
Gross Profit
288.81M 266.84M 219.53M 215.33M
Operating Income
58.87M 37.12M -24.97M -5M
Interest Income
n/a n/a n/a n/a
Pretax Income
57.29M 30.63M -29.99M -10.04M
Net Income
42.42M 67.44M -30.2M -10.29M
Selling & General & Admin
225.09M 211.12M 208.79M 198.36M
Research & Development
12.34M 12.66M 22.83M 17.34M
Other Expenses
-7.49M 5.94M 12.88M 4.61M
Operating Expenses
229.94M 229.73M 244.5M 220.31M
Interest Expense
1.01M 6.46M 5.02M 4.98M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
290.01M 284.36M 292.81M 263.6M
Income Tax Expense
15.3M -36.81M 206K 247K
Shares Outstanding (Basic)
146.98M 116.5M 112.91M 110.35M
Shares Outstanding (Diluted)
149.05M 145.96M 112.91M 110.35M
EPS (Basic)
0.29 0.48 -0.27 -0.09
EPS (Diluted)
0.28 0.38 -0.27 -0.09
EBITDA
64.34M 40.52M -10.69M -1.89M
EBIT
58.3M 37.09M -14.73M -7.07M
Depreciation & Amortization
6.04M 3.43M 4.05M 6.17M